DK2739270T3 - Ikke-fordøjelige kapsler til administration af fluidabsorberende materialer - Google Patents

Ikke-fordøjelige kapsler til administration af fluidabsorberende materialer Download PDF

Info

Publication number
DK2739270T3
DK2739270T3 DK12819632.6T DK12819632T DK2739270T3 DK 2739270 T3 DK2739270 T3 DK 2739270T3 DK 12819632 T DK12819632 T DK 12819632T DK 2739270 T3 DK2739270 T3 DK 2739270T3
Authority
DK
Denmark
Prior art keywords
administrating
extendable
caps
absorbing materials
fluid absorbing
Prior art date
Application number
DK12819632.6T
Other languages
English (en)
Inventor
Danielle Berger
Original Assignee
Hb Biotechnologies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hb Biotechnologies Corp filed Critical Hb Biotechnologies Corp
Application granted granted Critical
Publication of DK2739270T3 publication Critical patent/DK2739270T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/721Dextrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/738Cross-linked polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK12819632.6T 2011-08-01 2012-08-01 Ikke-fordøjelige kapsler til administration af fluidabsorberende materialer DK2739270T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161513923P 2011-08-01 2011-08-01
US201161523787P 2011-08-15 2011-08-15
PCT/US2012/049209 WO2013019891A1 (en) 2011-08-01 2012-08-01 Non-digestible capsules for the delivery of fluid absorbing materials

Publications (1)

Publication Number Publication Date
DK2739270T3 true DK2739270T3 (da) 2020-04-06

Family

ID=47629668

Family Applications (1)

Application Number Title Priority Date Filing Date
DK12819632.6T DK2739270T3 (da) 2011-08-01 2012-08-01 Ikke-fordøjelige kapsler til administration af fluidabsorberende materialer

Country Status (15)

Country Link
US (2) US20150216808A1 (da)
EP (1) EP2739270B1 (da)
JP (2) JP2014521689A (da)
CA (1) CA2842802C (da)
CY (1) CY1123430T1 (da)
DK (1) DK2739270T3 (da)
ES (1) ES2782523T3 (da)
HR (1) HRP20200463T1 (da)
HU (1) HUE049186T2 (da)
LT (1) LT2739270T (da)
PL (1) PL2739270T3 (da)
PT (1) PT2739270T (da)
RS (1) RS60294B1 (da)
SI (1) SI2739270T1 (da)
WO (1) WO2013019891A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11484579B2 (en) * 2017-11-29 2022-11-01 Edgar L Hull Vitamins and alpha keto acid compositions for use in a treatment program for chronic kidney disease patients

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE169293C1 (da) 1958-03-13 1959-11-10
US3042667A (en) 1959-03-10 1962-07-03 Pharmacia Ab Process for producing dextran derivatives and products resulting therefrom
SE319903B (da) 1964-01-31 1970-01-26 Pharmacia Ab
US3300474A (en) 1964-02-12 1967-01-24 Pharmacia Ab Sucrose ether copolymerizates
US3518340A (en) 1968-04-15 1970-06-30 Dow Corning Method of forming silicone rubber drug carriers
GB1348642A (en) * 1970-10-15 1974-03-20 Howard A N Hypocholesterolaemic compositions
US4470975A (en) * 1977-10-21 1984-09-11 The Johns Hopkins University Method and composition for the elimination of water from an animal body
JPS5858146A (ja) * 1981-10-05 1983-04-06 Tanabe Seiyaku Co Ltd 速放性マイクロカプセル
US4663148A (en) * 1984-03-21 1987-05-05 Alza Corporation Dispenser comprising telescopically engaging members
GB2155889B (en) * 1984-03-21 1988-03-02 Alza Corp Dispenser-capsule
GB8903564D0 (en) * 1989-02-16 1989-04-05 Rashid Abdul Drug dispensing device
DK0384646T3 (da) * 1989-02-16 1993-07-12 British Tech Group Dispenseringsindretning
US5264223A (en) * 1990-03-29 1993-11-23 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
US5169638A (en) * 1991-10-23 1992-12-08 E. R. Squibb & Sons, Inc. Buoyant controlled release powder formulation
GB9223172D0 (en) * 1992-11-05 1992-12-16 Scherer Corp R P Capsule construction
JP3238350B2 (ja) 1997-05-27 2001-12-10 三粧化研株式会社 可食性パール状カプセルおよびその製造法
CA2428800C (en) * 2000-11-20 2011-09-13 Dow Global Technologies Inc. In vivo use of fluid absorbent polymers
WO2002062356A2 (en) * 2001-02-06 2002-08-15 Ash Medical Systems, Inc. Monovalent-selective cation exchangers as oral sorbent therapy
NO20021592D0 (no) 2002-04-04 2002-04-04 Fmc Biopolymer As Polysakkaridkapsler og fremgangsmåte ved fremstilling derav
CA2498410A1 (en) * 2002-09-13 2004-03-25 Cydex, Inc. Capsules containing aqueous fill compositions stabilized with derivatized cyclodextrin
ES2274163T3 (es) * 2003-12-04 2007-05-16 Cognis Ip Management Gmbh Preparacion para su aplicacion (i) oral y/o topica.
WO2005084649A1 (ja) 2004-03-04 2005-09-15 Takeda Pharmaceutical Company Limited 安定なカプセル剤
US9233075B2 (en) * 2005-08-09 2016-01-12 Metacure Limited Satiety
JP5372525B2 (ja) 2006-03-03 2013-12-18 エフ エム シー コーポレーション カプセルの製造方法および該製造方法により製造されるカプセル
US8389003B2 (en) * 2006-03-29 2013-03-05 Eatlittle Inc. Ingestible implement for weight control
US20080268045A1 (en) * 2006-11-09 2008-10-30 Proprius Pharmaceuticals, Inc. Sustained release methotrexate formulations and methods of use thereof
GB0625180D0 (en) * 2006-12-15 2007-01-24 Mw Encap Ltd Improved hard shell capsules
US20110123604A1 (en) * 2007-08-29 2011-05-26 Sorbent Therapeutics, Inc. Absorbent polymeric compositions with varying counterion content and their methods of preparation and use
WO2009049105A2 (en) * 2007-10-09 2009-04-16 Gelesis, Inc. Methods for inducing satiation
WO2010065784A2 (en) * 2008-12-03 2010-06-10 Jakk Group, Inc. Methods, devices, and compositions for dermal filling
US20100291201A1 (en) * 2009-05-14 2010-11-18 Cerovene, Inc. Coated pharmaceutical capsule dosage form
US8101203B2 (en) * 2010-01-14 2012-01-24 Karl Wei Cao Hard capsule composition and method of use

Also Published As

Publication number Publication date
CA2842802A1 (en) 2013-02-07
JP2014521689A (ja) 2014-08-28
JP2017081973A (ja) 2017-05-18
WO2013019891A1 (en) 2013-02-07
CA2842802C (en) 2020-03-10
PT2739270T (pt) 2020-04-02
CY1123430T1 (el) 2021-12-31
ES2782523T3 (es) 2020-09-15
LT2739270T (lt) 2020-07-10
EP2739270A1 (en) 2014-06-11
JP6446071B2 (ja) 2018-12-26
EP2739270A4 (en) 2015-01-14
PL2739270T3 (pl) 2020-10-05
US20150216808A1 (en) 2015-08-06
EP2739270B1 (en) 2020-01-01
HRP20200463T1 (hr) 2020-06-26
HUE049186T2 (hu) 2020-09-28
SI2739270T1 (sl) 2020-10-30
RS60294B1 (sr) 2020-07-31
US20210330595A1 (en) 2021-10-28

Similar Documents

Publication Publication Date Title
DK3181128T3 (da) Farmaceutisk nilotinib-sammensætning
DK2812055T3 (da) Injektionsindretning til administration eller transport af fluidprodukt
DK2890434T3 (da) Lægemiddeladministrationsanordning
DK3639872T3 (da) Lægemiddeladministrationsanordning
DK2694038T3 (da) Farmaceutisk sammensætning
BR112014029530A2 (pt) compostos, composição farmacêutica e uso de um composto
BR112015000420A2 (pt) composto, composição farmacêutica, e, uso de um composto
DK2389918T3 (da) Anordning til indgivelse af væske i næse-øre-hals-området
BR112013030302A2 (pt) composto, composição farmacêutica, uso de um composto, combinação de um composto e dispositivo
BR112015002662A2 (pt) dispositivo para evaporar um fluido volátil
DK3381490T3 (da) Sikkerhedsindretninger til injektionsindretninger
DK2897594T3 (da) Farmaceutisk sammensætning
DK3003456T3 (da) Indretning til anvendelse af flydende lægemidler
BR112014009319A2 (pt) compostos farmacêuticos
DK2877677T3 (da) Strømningsbegrænser
DK2863985T3 (da) Anordning til forbedring af mikrocirkulering
BR112015005500A2 (pt) composto, composição farmacêutica, combinação de um composto, uso de um composto e dispositivo
DK2877409T3 (da) Væskebeholder
DK3345899T3 (da) Benzofuran-2-sulfonamidderivater som kemokinreceptormodulatorer
DK2739270T3 (da) Ikke-fordøjelige kapsler til administration af fluidabsorberende materialer
DE112013004054A5 (de) Fluidfilter
DE112012002424A5 (de) Fluidvorrichtung
BR112013022907A2 (pt) composição farmacêutica
DK2922571T3 (da) Farmaceutiske formuleringer, der omfatter carboran-holdige metallo-porphyriner
FI20126339A (fi) Tiivistyslaite